1. Home
  2. SSBI vs BMEA Comparison

SSBI vs BMEA Comparison

Compare SSBI & BMEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SSBI

Summit State Bank

N/A

Current Price

$13.22

Market Cap

91.6M

Sector

Finance

ML Signal

N/A

BMEA

Biomea Fusion Inc.

HOLD

Current Price

$1.29

Market Cap

91.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSBI
BMEA
Founded
1982
2017
Country
United States
United States
Employees
103
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
91.6M
91.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SSBI
BMEA
Price
$13.22
$1.29
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.83
AVG Volume (30 Days)
6.7K
508.2K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
69.19
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.35
$0.87
52 Week High
$14.00
$2.99

Technical Indicators

Market Signals
Indicator
SSBI
BMEA
Relative Strength Index (RSI) 49.20 52.27
Support Level $12.70 $1.28
Resistance Level $13.83 $1.44
Average True Range (ATR) 0.28 0.06
MACD 0.04 0.01
Stochastic Oscillator 69.17 78.05

Price Performance

Historical Comparison
SSBI
BMEA

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Share on Social Networks: